Maanei hiki iā ʻoe ke loaʻa i ka papa inoa o nā Top 10 Generic Nā Hui ʻo Pharma i ka Honua.
Ka papa inoa o nā 10 Generic Pharma Companies ma ka honua
Eia ka papa inoa o nā ʻoihana ʻoihana ʻoihana 10 kiʻekiʻe ma ka honua i hoʻokaʻawale ʻia e pili ana i nā kūʻai maʻamau.
1. Mylan ʻOihana Kamepiula
He honua ʻo Mylan ʻoihana hana lāʻau hoʻokō i ka hoʻonohonoho ʻana i nā kūlana hou i ka mālama olakino a hāʻawi i ka 7 biliona kānaka i loaʻa i ka lāʻau lapaʻau kiʻekiʻe. ʻO Mylan nā mea hana lāʻau lapaʻau nui loa ma ka honua.
- ʻOi aku ma mua o 7,500 huahana
- Mākeke: ʻoi aku ma mua o 165 mau ʻāina
ʻO ka generic Hui lāʻau lapaʻau hāʻawi i kahi kōpili e ulu nei o nā huahana ʻoi aku ma mua o 7,500, me nā lāʻau lapaʻau maʻamau, branded generic, brand-name a me nā lāʻau biosimilar, a me nā lāʻau lapaʻau ma luna o ka counter (OTC).
- Kūʻai maʻamau: $ 10.8 Billion
- limahana: 35,000
ʻO nā huahana mākeke o ka Hui ma mua o 165 mau ʻāina a me nā panalāʻau, a he 35,000 ka ikaika o ka hui i hoʻolaʻa ʻia no ka hoʻokumu ʻana i ke olakino maikaʻi no kahi honua maikaʻi aʻe.
2. ʻO Teva Pharmaceuticals
Ua hoʻokumu ʻia ʻo Teva Pharmaceuticals i ka makahiki 1901, ua hoʻohana nā mea mālama olakino me nā mea maʻi a me nā mea mālama i nā huahana generic a me nā mea hou. I kēia lā, ʻo ka hui ʻoihana ma kahi o 3,500 mau huahana i waena o ka nui o nā ʻoihana lāʻau lapaʻau ma ka honua.
- Kūʻai maʻamau: $ 9 Billion
Ma kahi kokoke i 200 miliona mau kānaka ma 60 mau ʻāina e pōmaikaʻi mai kekahi o nā lāʻau lapaʻau maikaʻi o Teva i kēlā me kēia lā. Hoʻokomo ka Generic Pharma Company i ka noiʻi a me ka hoʻomohala ʻana i nā lāʻau lapaʻau maʻamau a me nā biopharmaceuticals, e lawe ana i ka hoʻoilina o ka ʻoi aku o hoʻokahi haneli o ka ʻimi ʻana i nā ala hou e kōkua ai i nā maʻi e hoʻomaikaʻi i ko lākou ola.
Hōʻike kēia i nā waiwai ma ke ʻano he hui a hōʻike i ke ʻano o ka ʻoihana e hana ai i ka ʻoihana a hoʻokokoke i ka lāʻau lapaʻau. ʻO Teva i ka 2nd ka papa inoa o nā mea hana lāʻau lapaʻau maʻamau ma ka honua.
3. Novartis International
Ua hana ʻia ʻo Novartis ma 1996 ma o ka hui ʻana o Ciba-Geigy a me Sandoz. ʻO Novartis a me kāna mau ʻoihana mua i ʻike i nā aʻa ma mua o 250 mau makahiki, me ka mōʻaukala waiwai o ka hoʻomohala ʻana i nā huahana hou.
- Kūʻai maʻamau: $ 8.6 Billion
Aia ʻo Novartis i ka helu 4 ma Fortune Magazine's Most Admired Companies Ahalohalani papa inoa. Hana ʻia ʻelua ʻoihana ʻoihana - Novartis Pharmaceuticals e komo pū ana
- Novartis Gene Therapies, a
- ʻO Novartis Oncology
He alakaʻi honua ʻo Sandoz i nā lāʻau lapaʻau maʻamau a me nā biosimilars e pili ana i nā moʻolelo paionia e kōkua i nā poʻe a puni ka honua e komo i nā lāʻau lapaʻau kiʻekiʻe.
ʻO Novartis Global Product Portfolio a me Clinical Pipeline aia ma 155 mau ʻāina kahi e loaʻa ai nā huahana a me 200+ Projects i ka pipeline clinical. Aia ka hui ma waena o ka 50 lāʻau lapaʻau kiʻekiʻe a me ka generic.
4. Sun Pharmaceutical Industries Ltd
He hui lāʻau lapaʻau multinational India ia i hoʻokumu ʻia ma Mumbai, Maharashtra e hana a kūʻai aku i nā ʻano lāʻau lapaʻau a me nā mea lāʻau lapaʻau ikaika (API) ma India a me ʻAmelika Hui Pū ʻIa.
- Kūʻai maʻamau: $ 4 Billion
Hāʻawi ka hui ʻo Generic Pharma i nā ʻano hana i nā wahi lapaʻau like ʻole, e like me ka cardiology, psychiatry, neurology, gastroenterology, a me ka diabetology. Hāʻawi pū ia i nā API e like me warfarin, carbamazepine, etodolac, a me clorazepate, a me nā anti-cancers, steroids, peptides, sex hormones, a me nā mea hoʻomalu.
5. Pfizer
ʻO Pfizer kahi hui biopharmaceutical e pili ana i ka noiʻi. Ka Hui he hui lāʻau lapaʻau multinational ʻAmelika i hoʻokumu ʻia ma New York City. ʻO ia kekahi o nā hui lāʻau lapaʻau nui loa o ka honua a helu ʻia ʻo 57 ma ka 2018 Fortune 500 papa inoa o nā hui nui loa o ʻAmelika Hui Pū ʻIa ma ka huina kālā.
- Kūʻai maʻamau: $ 3.5 Billion
Hoʻohana ka Hui i ka ʻepekema a me nā kumuwaiwai honua e hoʻopuka i nā lāʻau lapaʻau hou e hoʻonui a hoʻomaikaʻi nui i nā ola. ʻO kekahi o nā lāʻau lapaʻau 50 kiʻekiʻe a me ka generic.
I kēlā me kēia lā, hana nā hoa hana ʻo Pfizer ma waena o nā mākeke hoʻomohala a e kū mai ana e holomua i ka maikaʻi, ka pale ʻana, ka mālama ʻana a me ka hoʻōla ʻana i nā maʻi weliweli loa o ko mākou manawa. ʻO 5 ma ka papa inoa o nā generic kiʻekiʻe mea lāʻau lapaʻau hui i ka honua.
6. ʻO Fresenius Medical Care
ʻO Fresenius Medical Care ka mea alakaʻi alakaʻi o ka honua i nā huahana a me nā lawelawe no ka poʻe me ka maʻi maʻi maʻi maʻi. Ma kahi o 3.5 miliona mau maʻi ma ka honua holoʻokoʻa me kēia maʻi e hana mau i ka mālama dialysis. ʻO ka dialysis kahi hana hoʻomaʻemaʻe koko ola e hoʻololi i ka hana o ka puʻupaʻa inā loaʻa ʻole ke kīpē.
- Kūʻai maʻamau: $ 3.2 Billion
Mālama ka Generic Pharma Company i nā mea maʻi ma mua o 347,000 i kā mākou pūnaewele puni honua o nā keʻena dialysis he 4,000. Ma waena o ka papa inoa o nā hui lāʻau lapaʻau maʻamau ma ka honua.
I ka manawa like, hoʻohana ka hui i nā kahua hana 45 ma mua o 20 mau ʻāina, e hoʻolako i nā huahana dialysis e like me nā mīkini dialysis, dialyzers a me nā mea pili.
7. Aurobindo Pharma
Hoʻokumuʻia ma 1986 na Mr. PV Ramprasad Reddy, Mr. K. Nityananda Reddy a me kahi pūʻulu liʻiliʻi o nāʻoihana koʻikoʻi nui, ua hānauʻiaʻo Aurobindo Pharma i kahi hihiʻo. Ua hoʻomaka ka hui i ka hana ma 1988-89 me kahi hoʻokahi ʻāpana hana Semi-Synthetic Penicillin (SSP) ma Pondicherry.
- Kūʻai maʻamau: $ 2.3 Billion
Ua lilo ʻo Aurobindo Pharma i hui aupuni ma 1992 a ua helu i kāna mau ʻāpana ma nā kumukūʻai kūʻai o India ma 1995. Ma waho aʻe o ka lilo ʻana i alakaʻi mākeke ma Semi-Synthetic Penicillins, aia ʻo Generic Pharma i nā ʻāpana therapeutic koʻikoʻi e like me neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology, and anti-biotics, a me nā mea ʻē aʻe.
ʻO kahi hui Pharma piha piha i India, Hōʻike ʻo Aurobindo Pharma i waena o nā ʻoihana 2 kiʻekiʻe ma India e pili ana i ka loaʻa kālā. Hoʻokuʻu aku ʻo Aurobindo i nā ʻāina he 150 a puni ka honua me ka ʻoi aku o 90% o kāna mau loaʻa i loaʻa mai nā hana honua.
8. Lupine
ʻO Lupine kahi hui lāʻau lapaʻau honua e hāʻawi ana i kahi ākea o nā huahana e like me Branded & Generic Formulations, Biotechnology Products, Active Pharmaceutical Ingredients (APIs) a me Specialty. Loaʻa i ka hui ka huina kūʻai o Rs 16718 Crs. ʻO Lupin ka papa honua Hoʻolaha ʻia nā hale hana ma India, Iapana, USA, Mexico, a me Brazil.
- Kūʻai maʻamau: $ 2.2 Billion
He mea pāʻani koʻikoʻi ʻo Lupine i nā wahi lapaʻau o Gynaecology, Cardiovascular, Diabetology, Asthma, Paediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective (AI) a me Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). ).
Loaʻa iā Lupin kahi kūlana alakaʻi honua ma nā ʻāpana Anti-TB a me Cephalosporins. Me ke komo ʻana i loko ma nāʻaoʻao 100, Hāʻawi ʻo Lupine i nā lāʻau lapaʻau kiʻekiʻe akā hiki ke kūpono no kekahi o nā maʻi maʻi maʻi e hoʻoponopono ana i nā pono kūpono ʻole ma nā wahi he nui o ka honua.
ʻO 10 mau ʻoihana Pharma ma India
9. Aspen Pharma
ʻO Generic Pharma Me kahi hoʻoilina 160 makahiki, ʻo Aspen kahi ʻoihana kūikawā honua a me nā ʻoihana lapaʻau multinational branded me ka noho ʻana ma nā mākeke ulu a hoʻomohala ʻia me kahi o 10 000 mau limahana ma 70 mau hana ʻoihana i hoʻokumu ʻia ma 55 mau ʻāina.
Hoʻomaikaʻi ka Hui Generic Pharma i ke olakino o nā maʻi ma mua o 150 mau ʻāina ma o kā mākou huahana kiʻekiʻe. ʻO nā ʻāpana ʻoihana koʻikoʻi ʻo Generic Pharma Company ka Manufacturing and Commercial Pharmaceuticals e pili ana i nā Regional Brands a me Sterile Focus Brands e komo pū ana me nā huahana Anesthetics a me Thrombosis.
- Kūʻai maʻamau: $ 2 Billion
Hiki i ka hui hana ke uhi i nā ʻano huahana like ʻole me nā injectables, waha solid dose, wai, semi-solids, steriles, biologicals a me nā mea lāʻau lapaʻau ikaika.
Hoʻohana ka Generic Pharma Company i nā hale hana 23 ma nā pūnaewele 15 a paʻa mākou i nā ʻae hana hana honua mai kekahi o nā ʻoihana hoʻoponopono honua koʻikoʻi e pili ana, me kekahi, ʻo ka United States Food and Drug Administration, Australian Therapeutic Goods Administration a me ka European Directorate no ka Ka maikai o na Laau Laau.
10. ʻO Amneal Pharmaceuticals, Inc
ʻO Amneal Pharmaceuticals, Inc. (NYSE: AMRX) he hui lāʻau lapaʻau kūikawā i hoʻohui ʻia e kahi ʻoihana maʻamau US ikaika a me kahi ʻoihana e ulu nei. Ke hana nei ka hui e kūkulu i kekahi o nā ʻoihana lāʻau lapaʻau ikaika loa i ka hoʻololi wikiwiki ʻana i ka ʻoihana.
- Kūʻai maʻamau: $ 1.8 Billion
ʻO Generic Pharma ka Hui i ka hāʻawi ʻana i nā hopena e kū ana i nā pono olakino koʻikoʻi, e hana i nā lāʻau lapaʻau maikaʻi i ʻoi aku ka maʻalahi a ʻoi aku ke kumukūʻai, a hāʻawi i nā hoʻonā no nā pilikia olakino o ka lā ʻapōpō. Ma waena o nā mea hana lāʻau lapaʻau maʻamau ma ka honua.
No laila ʻo kēia ka papa inoa o nā mea hana lāʻau lapaʻau maʻamau ma ka honua.
Makemake au e hoʻomaka i ka ʻoihana kūʻai nui o ka lāʻau lapaʻau jenric.
Manaʻo pāʻoihana
He pou blog maikaʻi loa ia. Heluhelu mau wau i kāu blog i nā ʻōlelo aʻoaʻo e kōkua ai a ʻike. Makemake wau iā ia no ka hāʻawi ʻana mai i kēia ʻike iā mākou
Mahalo nui iā ʻoe no ke kākau ʻana i ka blog informative i wehewehe maikaʻi ʻia. He mea maikaʻi loa ka ʻike ʻana i ka poʻe e loaʻa ana ka ʻike olakino koʻikoʻi ma ka pūnaewele a mahalo nui i ka poʻe e like me ʻoe nāna i hoʻokomo iā mākou ma ke ala maopopo loa.